1. Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide. (August 2018) Authors: McTyre, Emory; Lucas, John T.; Helis, Corbin; Farris, Michael; Soike, Michael; Mott, Ryan; Laxton, Adrian W.; Tatter, Stephen B.; Lesser, Glenn J.; Strowd, Roy E.; Lo, Hui-Wen; Debinski, Waldemar; Chan, Michael D. Journal: American journal of clinical oncology Issue: Volume 41:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pearls & Oy-sters: The critical role of histopathology in diagnosing cancer-associated necrotizing CNS vasculitis. (24th April 2018) Authors: Sheehan, Joshua; Tate, Jessica; Mott, Ryan; Geer, Carol; Wolfe, Rachel; Strowd, Roy E.; Guzik, Amy Journal: Neurology Issue: Volume 90:Number 17(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RADT-16. CLINICAL OUTCOMES FOR HIGH RISK WHO GRADE II GLIOMA PATIENTS TREATED WITH UPFRONT TMZ-BASED CHEMORADIOTHERAPY. (14th November 2022) Authors: Zarabi, Hosniya; Wicks, Robert; Russel, Gregory; Banderage, Dineth; Strowd, Roy; Mott, Ryan; Laxton, Adrian; Tatter, Stephen; White, Jaclyn; Lo, Hui-Wen; Debinski, Waldemar; Chan, Michael; Lesser, Glenn; Cramer, Christina Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗